# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
171, Journal, 0, 10, "Horm Res .", "", "<http://ctro/data#Publication_26195> <http://ctro/data#hasJournal> \"Horm Res .\"."
0, PublicationYear, 11, 15, "2004", "", "<http://ctro/data#Publication_26195> <http://ctro/data#hasPublicationYear> \"2004\"."
84, Title, 57, 130, "Does bromocriptine improve glycemic control of obese type - 2 diabetics ?", "", "<http://ctro/data#Publication_26195> <http://ctro/data#hasTitle> \"Does bromocriptine improve glycemic control of obese type - 2 diabetics ?\"."
73, Bromocriptine, 62, 75, "bromocriptine", "", 
75, Precondition, 104, 128, "obese type - 2 diabetics", "", 
74, Type2Diabetes, 110, 128, "type - 2 diabetics", "", 
23, Author, 131, 144, "Aminorroaya A", "", "<http://ctro/data#Publication_26195> <http://ctro/data#hasAuthor> \"Aminorroaya A\"."
24, Author, 153, 166, "Janghorbani M", "", "<http://ctro/data#Publication_26195> <http://ctro/data#hasAuthor> \"Janghorbani M\"."
25, Author, 169, 179, "Ramezani M", "", "<http://ctro/data#Publication_26195> <http://ctro/data#hasAuthor> \"Ramezani M\"."
26, Author, 182, 192, "Haghighi S", "", "<http://ctro/data#Publication_26195> <http://ctro/data#hasAuthor> \"Haghighi S\"."
27, Author, 195, 202, "Amini M", "", "<http://ctro/data#Publication_26195> <http://ctro/data#hasAuthor> \"Amini M\"."
2, Iran, 358, 362, "Iran", "", "<http://ctro/data#Population_26222> <http://ctro/data#hasCountry> <http://ctro/data#Iran>."
76, OralAntidiabeticAgent, 420, 444, "oral hypoglycemic agents", "", 
40, Type2Diabetes, 479, 496, "type - 2 diabetic", "", 
173, PlasmaGlucose, 525, 539, "plasma glucose", "", 
41, Bromocriptine, 628, 641, "bromocriptine", "", 
167, ObjectiveDescription, 705, 802, "the effect of bromocriptine on glycemic control was evaluated in obese type - 2 diabetic patients", "", "<http://ctro/data#ClinicalTrial_26206> <http://ctro/data#hasObjectiveDescription> \"32\". <http://ctro/data#ClinicalTrial_26206> <http://ctro/data#hasObjectiveDescription> \"the effect of bromocriptine on glycemic control was evaluated in obese type - 2 diabetic patients\"."
42, Bromocriptine, 719, 732, "bromocriptine", "", 
3, Precondition, 770, 802, "obese type - 2 diabetic patients", "", 
43, Type2Diabetes, 776, 793, "type - 2 diabetic", "", 
7, DoubleBlind, 820, 834, "double - blind", "", "<http://ctro/data#ClinicalTrial_26206> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind>."
100, Placebo, 835, 842, "placebo", "", 
6, NumberPatientsCT, 873, 875, "40", "", "<http://ctro/data#ClinicalTrial_26206> <http://ctro/data#hasNumberPatientsCT> \"40\"."
77, Precondition, 876, 913, "obese patients with type - 2 diabetes", "", "<http://ctro/data#Population_26222> <http://ctro/data#hasPrecondition> \"obese patients with type - 2 diabetes\"."
44, Type2Diabetes, 896, 913, "type - 2 diabetes", "", "<http://ctro/data#ClinicalTrial_26206> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes>."
4, MinAge, 921, 923, "32", "", "<http://ctro/data#Population_26222> <http://ctro/data#hasMinAge> \"32\"."
5, MaxAge, 926, 928, "70", "", "<http://ctro/data#Population_26222> <http://ctro/data#hasMaxAge> \"70\"."
92889, Randomized, 942, 950, "randomly", "", "<http://ctro/data#ClinicalTrial_26206> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
45, Bromocriptine, 1016, 1029, "bromocriptine", "", "<http://ctro/data#Medication_26281> <http://ctro/data#hasDrug> <http://ctro/data#Bromocriptine>."
10, DoseValue, 1032, 1037, "2 . 5", "", "<http://ctro/data#Medication_26281> <http://ctro/data#hasDoseValue> \"2 . 5\"."
11, mg, 1038, 1040, "mg", "", "<http://ctro/data#Medication_26281> <http://ctro/data#hasDoseUnit> <http://ctro/data#mg>."
78, Frequency, 1041, 1046, "daily", "", "<http://ctro/data#Intervention_26269> <http://ctro/data#hasFrequency> \"daily\"."
9, Duration, 1064, 1072, "3 months", "", 
46, Placebo, 1101, 1108, "placebo", "", "<http://ctro/data#Medication_26288> <http://ctro/data#hasDrug> <http://ctro/data#Placebo>."
113, Precondition, 1125, 1249, "uncontrolled on fixed doses of glibenclamide or its combination with metformin in the 3 months before enrolling in the study", "", "<http://ctro/data#Population_26222> <http://ctro/data#hasPrecondition> \"uncontrolled on fixed doses of glibenclamide or its combination with metformin in the 3 months before enrolling in the study\"."
115, Drug, 1156, 1169, "glibenclamide", "", 
114, Metformin, 1194, 1203, "metformin", "", 
38176, Duration, 1211, 1219, "3 months", "", 
47, FastingPlasmaGlucose, 1256, 1278, "fasting plasma glucose", "", 
48, FastingPlasmaGlucose, 1281, 1284, "FPG", "", 
49, HbA1c, 1297, 1320, "glycosylated hemoglobin", "", 
50, HbA1c, 1323, 1327, "HbA1", "", 
51, BMI, 1348, 1363, "body mass index", "", 
52, BMI, 1366, 1369, "BMI", "", 
38177, TimePoint, 1398, 1416, "1 , 2 and 3 months", "", 
38178, TimePoint, 1402, 1416, "2 and 3 months", "", 
38179, TimePoint, 1408, 1416, "3 months", "", 
12, FastingPlasmaGlucose, 1449, 1452, "FPG", "", "<http://ctro/data#Endpoint_26231> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#FastingPlasmaGlucose>."
53, Bromocriptine, 1476, 1489, "bromocriptine", "", 
28, BaseLineValue, 1511, 1518, "10 . 59", "", "<http://ctro/data#Outcome_26295> <http://ctro/data#hasBaselineValue> \"10 . 59\"."
33, SdErrorBL, 1525, 1531, "0 . 42", "", "<http://ctro/data#Outcome_26295> <http://ctro/data#hasSdErrorBL> \"0 . 42\"."
124, ResultMeasuredValue, 1535, 1541, "9 . 06", "", "<http://ctro/data#Outcome_26295> <http://ctro/data#hasResultMeasuredValue> \"9 . 06\"."
125, SdErrorResValue, 1548, 1554, "0 . 41", "", "<http://ctro/data#Outcome_26295> <http://ctro/data#hasSdErrorResValue> \"0 . 41\"."
54, Millimoles_per_litre, 1555, 1563, "mmol / l", "", 
170, Mean, 1566, 1570, "mean", "", 
38180, PValueChangeValue, 1583, 1593, "p < 0 . 01", "", "<http://ctro/data#Outcome_26295> <http://ctro/data#hasPValueChangeValue> \"p < 0 . 01\"."
55, Placebo, 1613, 1620, "placebo", "", 
29, BaseLineValue, 1648, 1655, "10 . 69", "", "<http://ctro/data#Outcome_26322> <http://ctro/data#hasBaselineValue> \"10 . 69\"."
34, SdErrorBL, 1662, 1668, "0 . 52", "", "<http://ctro/data#Outcome_26322> <http://ctro/data#hasSdErrorBL> \"0 . 52\"."
130, ResultMeasuredValue, 1673, 1679, "10 . 6", "", "<http://ctro/data#Outcome_26322> <http://ctro/data#hasResultMeasuredValue> \"10 . 6\"."
131, SdErrorResValue, 1686, 1692, "0 . 57", "", "<http://ctro/data#Outcome_26322> <http://ctro/data#hasSdErrorResValue> \"0 . 57\"."
56, Millimoles_per_litre, 1693, 1701, "mmol / l", "", 
57, HbA1c, 1723, 1727, "HbA1", "", "<http://ctro/data#Endpoint_26236> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c>."
58, Bromocriptine, 1761, 1774, "bromocriptine", "", 
30, BaseLineValue, 1796, 1801, "9 . 9", "", "<http://ctro/data#Outcome_26349> <http://ctro/data#hasBaselineValue> \"9 . 9\"."
35, SdErrorBL, 1808, 1813, "0 . 3", "", "<http://ctro/data#Outcome_26349> <http://ctro/data#hasSdErrorBL> \"0 . 3\"."
137, ResultMeasuredValue, 1817, 1822, "9 . 5", "", "<http://ctro/data#Outcome_26349> <http://ctro/data#hasResultMeasuredValue> \"9 . 5\"."
138, SdErrorResValue, 1829, 1834, "0 . 2", "", "<http://ctro/data#Outcome_26349> <http://ctro/data#hasSdErrorResValue> \"0 . 2\"."
80, Percentage, 1835, 1836, "%", "", "<http://ctro/data#Endpoint_26236> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage>."
63, PValueChangeValue, 1839, 1849, "p = 0 . 06", "", "<http://ctro/data#Outcome_26349> <http://ctro/data#hasPValueChangeValue> \"p = 0 . 06\"."
61, Placebo, 1882, 1889, "placebo", "", 
31, BaseLineValue, 1911, 1917, "10 . 2", "", "<http://ctro/data#Outcome_26376> <http://ctro/data#hasBaselineValue> \"10 . 2\"."
36, SdErrorBL, 1924, 1929, "0 . 3", "", "<http://ctro/data#Outcome_26376> <http://ctro/data#hasSdErrorBL> \"0 . 3\"."
144, ResultMeasuredValue, 1933, 1939, "11 . 3", "", "<http://ctro/data#Outcome_26376> <http://ctro/data#hasResultMeasuredValue> \"11 . 3\"."
62, SdErrorChangeValue, 1946, 1951, "0 . 6", "", "<http://ctro/data#Outcome_26376> <http://ctro/data#hasSdErrorChangeValue> \"0 . 6\"."
81, Percentage, 1952, 1953, "%", "", 
17, PValueChangeValue, 1956, 1966, "p < 0 . 05", "", "<http://ctro/data#Outcome_26376> <http://ctro/data#hasPValueChangeValue> \"p < 0 . 05\"."
64, HbA1c, 1990, 1994, "HbA1", "", 
154, DiffGroupAbsValue, 1997, 2002, "1 . 8", "", "<http://ctro/data#DiffBetweenGroups_26403> <http://ctro/data#hasDiffGroupAbsValue> \"1 . 8\"."
155, Percentage, 2003, 2004, "%", "", 
19, PvalueDiff, 2007, 2017, "p < 0 . 01", "", 
65, FastingPlasmaGlucose, 2024, 2027, "FPG", "", 
20, DiffGroupAbsValue, 2030, 2036, "1 . 55", "", 
22, Millimoles_per_litre, 2037, 2045, "mmol / l", "", 
21, PvalueDiff, 2048, 2058, "p < 0 . 05", "", 
66, Bromocriptine, 2080, 2093, "bromocriptine", "", 
67, Placebo, 2098, 2105, "placebo", "", 
158, TimePoint, 2116, 2124, "3 months", "", 
179, ObservedResult, 2144, 2257, "No changes in body weight or BMI occurred during the study in either placebo - or bromocriptine - treated group .", "", "<http://ctro/data#Outcome_26421> <http://ctro/data#hasObservedResult> \"double - blind\". <http://ctro/data#Outcome_26421> <http://ctro/data#hasObservedResult> \"No changes in body weight or BMI occurred during the study in either placebo - or bromocriptine - treated group .\". <http://ctro/data#Outcome_26448> <http://ctro/data#hasObservedResult> \"double - blind\". <http://ctro/data#Outcome_26448> <http://ctro/data#hasObservedResult> \"No changes in body weight or BMI occurred during the study in either placebo - or bromocriptine - treated group .\"."
13, BodyWeight, 2158, 2169, "body weight", "", "<http://ctro/data#Endpoint_26241> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#BodyWeight>."
68, BMI, 2173, 2176, "BMI", "", "<http://ctro/data#Endpoint_26246> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#BMI>."
69, Placebo, 2213, 2220, "placebo", "", 
70, Bromocriptine, 2226, 2239, "bromocriptine", "", 
168, ConclusionComment, 2271, 2451, "The data further support the contention that bromocriptine improves glycemic control in obese type - 2 diabetic patients , although the mechanism of action remains to be determined", "", "<http://ctro/data#ClinicalTrial_26206> <http://ctro/data#hasConclusionComment> \"The data further support the contention that bromocriptine improves glycemic control in obese type - 2 diabetic patients , although the mechanism of action remains to be determined\". <http://ctro/data#ClinicalTrial_26206> <http://ctro/data#hasConclusionComment> \"70\"."
71, Bromocriptine, 2316, 2329, "bromocriptine", "", 
79, Precondition, 2359, 2391, "obese type - 2 diabetic patients", "", 
72, Type2Diabetes, 2365, 2382, "type - 2 diabetic", "", 
1, PMID, 2489, 2497, "15205563", "", 
